Explore the Latest #NephTrials Discussion on Dapagliflozin and CKD on the ISN’s Twitter Feed
The latest #NephTrials online discussion took place on March 10. Access the Twitter thread here. Twitter attendees joined Ron Gansevoort, Roberto Pecoits-Filho, Joel Topf, Manasi Bapat, and Swapnil Hiremath to discuss the RENAL LIFECYCLE trial. The conversation examined the composite and secondary outcomes of a randomized control trial investigating the effects of dapagliflozin on people with severe...